Status:
NOT_YET_RECRUITING
Genomics in Heart Transplants
Lead Sponsor:
Heinrich-Heine University, Duesseldorf
Conditions:
Heart Transplantation
Eligibility:
All Genders
18+ years
Brief Summary
A cross-sectional analysis of 200 heart transplant recipients, combining in-depth phenotyping and risk factor assessment (cardiac MRI, coronary angiogram with OCT, cardiorespiratory exercise tests, ex...
Detailed Description
Background: Heart transplantation (HTx) is the treatment of choice for patients with end-stage heart failure who remain symptomatic despite optimal medical therapy. Even with best-practice follow-up c...
Eligibility Criteria
Inclusion
- Patients \> 18 years old undergoing heart transplantation in our centre
Exclusion
- \< 18 years
- incapable of giving consent
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2028
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06012162
Start Date
January 1 2024
End Date
January 1 2028
Last Update
August 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University-Hospital Düsseldorf Division of Cardiology, Pulmonary Disease and Vascular Medicine
Düsseldorf, Germany, 40225